Tumor cells target metastases as they die

A new drug can eliminate cancer cells while training the immune system to destroy such cells throughout the body

23-Jul-2025
AI-generated image

Symbolic image

Two junior research groups at Ruhr University Bochum, Germany, have developed a drug complex that kills cancer cells in such a clever manner that they raise a red flag as they die. They signal to the immune system that something is seriously wrong with this type of cell. This teaches the immune cells to destroy such cancer cells—even if they are not in the vicinity of the original tumor. This could remove metastases that develop at distant sites in the body. Dr. Johannes Karges from the Department of Chemistry and Biochemistry and Dr. Carlos Plaza-Sirvent from the Department of Medicine present their findings in the Journal of Medicinal Chemistry on July 17, 2025.

Uncommon: immunogenic cell death

90 percent of all deaths from cancer are due to metastases. This is why Karges and his team are looking for ways to train the immune system to target and eliminate cancer cells. They have found success with a drug that kills the cells in a sophisticated manner. “The gallium complex we developed penetrates the cells and, because of its special properties, causes oxidative stress in a certain cell organelle known as the endoplasmic reticulum,” he explains. “The cells then undergo immunogenic cell death, which only very few drugs can achieve.”

Immune system learns to identify cancer cells

Through this type of cell death, proteins from the endoplasmic reticulum and the cell nucleus are released to the outside and act as a strong warning signal to the immune system: Something is wrong here, these cells are harmful. This teaches the immune system to recognize the cancer cells as hostile and eliminate them throughout the body. This should also destroy metastases.

The two teams led by Johannes Karges and Carlos Plaza-Sirvent have successfully tested the active ingredient on cervical cancer cell lines. The next step is to package it in such a way that it accumulates specifically in cancer cells and is effective only there, and not in all cells of the body. Karges' research group has already developed various methods for this, for example, which active ingredients are activated by an external signal such as ultrasound or light.

Original publication

Zisis Papadopoulos, Yassin Antar, Irma-Sofie Dieter, Frank Peeters, Carlos Plaza-Sirvent, Johannes Karges: Gallium(III) Complex Induces Immunogenic Cell Death Hallmarks for Chemoimmunotherapy, in: Journal of Medicinal Chemistry, 2025

Other news from the department science

Most read news

More news from our other portals

So close that even
molecules turn red...

Last viewed contents

Transforming personalized medicine with AI-driven CAR-T manufacturing - Automated CAR-T cell production platform is ready for production

Transforming personalized medicine with AI-driven CAR-T manufacturing - Automated CAR-T cell production platform is ready for production

Edible, biodegradable fibers made from milk protein, cellulose - Sustainable food packaging, wound dressings, cosmetics, filtration and more are all areas in which work is showing promise

Edible, biodegradable fibers made from milk protein, cellulose - Sustainable food packaging, wound dressings, cosmetics, filtration and more are all areas in which work is showing promise

Siemens completes acquisition of Dotmatics - Acquisition expanding Siemens’ offerings into the life sciences industry

Siemens completes acquisition of Dotmatics - Acquisition expanding Siemens’ offerings into the life sciences industry

A possible replacement for plastic could lead to stronger, eco-friendly materials for everyday use - It has the potential to become your next disposable water bottle, and so much more

A possible replacement for plastic could lead to stronger, eco-friendly materials for everyday use - It has the potential to become your next disposable water bottle, and so much more

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine - Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine - Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

Scientists uncover DNA secrets to bolster corn crop traits - The discovery could enable scientists to use new technologies to improve corn, making it more resilient and productive

Scientists uncover DNA secrets to bolster corn crop traits - The discovery could enable scientists to use new technologies to improve corn, making it more resilient and productive

Researchers develop process to turn food waste into biodegradable plastic - New process uses bacteria

Researchers develop process to turn food waste into biodegradable plastic - New process uses bacteria

Turning poison into a source of energy - A research team lhas succeeded in genetically manipulating the microorganism T. kivui to metabolize carbon monoxide

Turning poison into a source of energy - A research team lhas succeeded in genetically manipulating the microorganism T. kivui to metabolize carbon monoxide

Pigments that can do more - New discovery sheds light on the bacterial use of biomass with potential for biofuels and new antibiotics

Pigments that can do more - New discovery sheds light on the bacterial use of biomass with potential for biofuels and new antibiotics

Research team achieves breakthrough in environmentally friendly control of invasive pests - Solving a 35-year-old puzzle paves the way for sustainable control of insect pests worldwide

Research team achieves breakthrough in environmentally friendly control of invasive pests - Solving a 35-year-old puzzle paves the way for sustainable control of insect pests worldwide

Synthesizing fine chemicals: Technological Advance in Production of Pharmaceuticals

Synthesizing fine chemicals: Technological Advance in Production of Pharmaceuticals

Evotec announces sale of API manufacturing facility to Monacum Partners - New ownership committed to maintaining and growing the business

Evotec announces sale of API manufacturing facility to Monacum Partners - New ownership committed to maintaining and growing the business